Physician profile
Hernando Garcia
NPI 1922000314
$18,231.32
in general payments reported to CMS, 2019-2025
36 companies · $1,537 in 2025
The $1,537 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $418 · 2021: $652 · 2022: $3,832 · 2023: $2,667 · 2024: $8,812 · 2025: $1,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,673 · Food and Beverage: $4,343 · Travel and Lodging: $800 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,673.00 |
| Food and Beverage | $4,342.97 |
| Travel and Lodging | $800.33 |
| Education | $199.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $7,943.54 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Actelion Pharmaceuticals US, INC. | $3,739.67 | 2019-2025 | Opsumit, Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $1,545.79 | 2020-2025 | |
| Glaxosmithkline, LLC. | $1,238.99 | 2021-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $1,126.35 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Inari Medical, INC. | $350.15 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $298.86 | 2020-2025 | Ofev, Jascayd |
| Amgen INC. | $225.56 | 2023-2025 | Tezspire |
| Ambu INC. | $188.05 | 2021-2022 | |
| Stryker Corporation | $184.09 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Grifols USA, LLC | $176.05 | 2020-2023 | Prolastin-C Liquid |
| Genzyme Corporation | $155.48 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $148.34 | 2023 | Glassia |
| Inspire Medical Systems, INC. | $139.53 | 2024 | Inspire |
| Merck Sharp & Dohme LLC | $100.31 | 2024-2025 | Winrevair |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $82.00 | 2023-2024 | Yupelri |
| Verona Pharma, INC. | $79.40 | 2025 | Ohtuvayre |
| Ani Pharmaceuticals, INC. | $60.10 | 2023 | Purified Cortrophin Gel |
| Philips North America LLC | $55.62 | 2022-2025 | Vest Therapy Und |
| Vyaire Medical, INC. | $42.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $34.64 | 2023 | Dupixent |
| Inogen, INC. | $30.32 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Alnylam Pharmaceuticals INC. | $27.86 | 2024 | Onpattro |
| Abbvie INC. | $26.24 | 2023 | |
| Janssen Pharmaceuticals, INC | $25.75 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $23.88 | 2024 | Prolaris |
| Vapotherm INC | $23.81 | 2021 | |
| Pulmonx Corporation | $22.26 | 2023 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Neurocrine Biosciences, INC. | $20.33 | 2025 | |
| Abbott Laboratories | $20.06 | 2024 | Freestyle Libre |
| Halozyme INC | $17.87 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $17.49 | 2021 | |
| Boston Scientific Corporation | $16.59 | 2022 | |
| Novo Nordisk INC | $15.52 | 2023 | Ozempic, Rybelsus |
| Cardinal Health 200 LLC | $14.99 | 2020 | |
| Angiodynamics, INC. | $13.83 | 2023 | Nanoknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hernando Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.